Kodiak Sciences
KOD· Manufacturing· Fiscal year ends in December
Victor Perlroth, M.D is the CEO of Kodiak Sciences and was paid $2.5M in FY2025 (Dec), up 26%.
Executives2
See all- 1Victor Perlroth, M.DChief Executive Officer and Chairman of the BoardFY2025
- 2John A. BorgesonExecutive Vice President, Chief Financial Officer and SecretaryFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allKodiak Sciences paid its 2 named executives $4.1M in total in FY2025 (Dec). CEO Victor Perlroth, M.D was paid $2.5M of that.
| Name | |||
|---|---|---|---|
| Victor Perlroth, M.DChief Executive Officer and Chairman of the Board | |||
| John A. BorgesonExecutive Vice President, Chief Financial Officer and Secretary |
of each named executive, from the Summary Compensation Table of each proxy.
Peers17
See allThe FY2025 (Dec) proxy of Kodiak Sciences names 17 peer companies for pay. Among Kodiak Sciences and these peers, CEO pay was 8th highest of 10 and total shareholder return was the highest of 10.
8th highest of 10in Kodiak Sciences and its pay peers, FY2025 (Dec) by CEO pay:
1st highest of 10in Kodiak Sciences and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Felix J. BakerDirector · 10 yr on the boardIndependentCompensation (Chair)—Paid as an executive
- Bassil I. DahiyatDirector · 7 yr on the boardIndependent—Paid as an executive
- Richard Levy, M.D.Director · 7 yr on the boardIndependent—Paid as an executive
- Taiyin YangDirector · 6 yr on the boardIndependent—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 22, 2026 | FY2025 |
| Annual report | 10-K | Mar 31, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 22, 2025 | FY2024 |
| Annual report | 10-K | Mar 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 23, 2024 | FY2023 |
| Annual report | 10-K | Mar 28, 2024 | FY2023 |